Rankings
▼
Calendar
ELUT Q3 2025 Earnings — Elutia Inc. Revenue & Financial Results | Market Cap Arena
ELUT
Elutia Inc.
$48M
Q3 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$3M
-43.9% YoY
Gross Profit
$2M
55.8% margin
Operating Income
-$5M
-156.7% margin
Net Income
-$4M
-116.4% margin
EPS (Diluted)
$-0.19
QoQ Revenue Growth
-46.9%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$4M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$29M
Total Liabilities
$73M
Stockholders' Equity
-$44M
Cash & Equivalents
$5M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$3M
$6M
-43.9%
Gross Profit
$2M
$3M
-32.4%
Operating Income
-$5M
-$10M
+49.1%
Net Income
-$4M
$1M
-400.8%
Revenue Segments
Women's Health
$2M
72%
Cardiovascular
$944,000
28%
← Q2 2025
All Quarters